1 rich Libsyn https://www.libsyn.com 90 600 JCO Editorial Fellow Dr. Ash Gurumurthi and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2026 Simultaneous Publication paper &quot;Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 Study.&quot; LINK TO FULL TRANSCRIPT Journal of Clinical Oncology (JCO) Podcast http://sites.libsyn.com/58526 <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/41396325/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/00457c/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/202231560